Medserv has announced that it has appointed Edison Investment Research to carry out analytical investment research on the company. This will be in the form of periodic reports which will be made available to the general public and which will be posted on the company website. The first report has been compiled and has been published today.
These reports will be compiled by Edison solely on the basis of information already in the public arena. Any forward looking statements and projections that may be contained in the reports reflect solely the views of Edison themselves.
Medserv is the first publically quoted company in Malta to engage independent analysts to report on their performance and market outlook. “We have always advocated the importance of transparency and appreciate the value of providing our shareholders and the market in general with information and the visibility they require.” said Mr Duncan, Director at Medserv plc. “This recent engagement of a reputed, independent analyst continues to solidify our commitment to the market. Furthermore Edison’s global reach will further assist Medserv in its ambitions to spread its name beyond the areas in which it presently operates.”